The U.S. Food and Drug Administration has approved the FluMist Quadrivalent, the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.
Read the full report in Becker’s Hospital Review on FluMist Quadrivalent.
